Copyright Reports & Markets. All rights reserved.

Global Colorectal Cancer Molecular Diagnostics Kit Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Colorectal Cancer Molecular Diagnostics Kit by Type
    • 1.3.1 Overview: Global Colorectal Cancer Molecular Diagnostics Kit Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Colorectal Cancer Molecular Diagnostics Kit Consumption Value Market Share by Type in 2025
    • 1.3.3 PCR
    • 1.3.4 Molecular Hybridization
    • 1.3.5 Biochip
    • 1.3.6 Other
  • 1.4 Global Colorectal Cancer Molecular Diagnostics Kit Market by Application
    • 1.4.1 Overview: Global Colorectal Cancer Molecular Diagnostics Kit Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Third-party Testing Agency
    • 1.4.4 Other
  • 1.5 Global Colorectal Cancer Molecular Diagnostics Kit Market Size & Forecast
  • 1.6 Global Colorectal Cancer Molecular Diagnostics Kit Market Size and Forecast by Region
    • 1.6.1 Global Colorectal Cancer Molecular Diagnostics Kit Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Colorectal Cancer Molecular Diagnostics Kit Market Size by Region, (2021-2032)
    • 1.6.3 North America Colorectal Cancer Molecular Diagnostics Kit Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Colorectal Cancer Molecular Diagnostics Kit Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Colorectal Cancer Molecular Diagnostics Kit Market Size and Prospect (2021-2032)
    • 1.6.6 South America Colorectal Cancer Molecular Diagnostics Kit Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Colorectal Cancer Molecular Diagnostics Kit Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Colorectal Cancer Molecular Diagnostics Kit Product and Solutions
    • 2.1.4 Roche Colorectal Cancer Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Roche Recent Developments and Future Plans
  • 2.2 Abbott
    • 2.2.1 Abbott Details
    • 2.2.2 Abbott Major Business
    • 2.2.3 Abbott Colorectal Cancer Molecular Diagnostics Kit Product and Solutions
    • 2.2.4 Abbott Colorectal Cancer Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Abbott Recent Developments and Future Plans
  • 2.3 Thermo Fisher
    • 2.3.1 Thermo Fisher Details
    • 2.3.2 Thermo Fisher Major Business
    • 2.3.3 Thermo Fisher Colorectal Cancer Molecular Diagnostics Kit Product and Solutions
    • 2.3.4 Thermo Fisher Colorectal Cancer Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Thermo Fisher Recent Developments and Future Plans
  • 2.4 Kej
    • 2.4.1 Kej Details
    • 2.4.2 Kej Major Business
    • 2.4.3 Kej Colorectal Cancer Molecular Diagnostics Kit Product and Solutions
    • 2.4.4 Kej Colorectal Cancer Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Kej Recent Developments and Future Plans
  • 2.5 Illumina
    • 2.5.1 Illumina Details
    • 2.5.2 Illumina Major Business
    • 2.5.3 Illumina Colorectal Cancer Molecular Diagnostics Kit Product and Solutions
    • 2.5.4 Illumina Colorectal Cancer Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Illumina Recent Developments and Future Plans
  • 2.6 Bio Mérieux
    • 2.6.1 Bio Mérieux Details
    • 2.6.2 Bio Mérieux Major Business
    • 2.6.3 Bio Mérieux Colorectal Cancer Molecular Diagnostics Kit Product and Solutions
    • 2.6.4 Bio Mérieux Colorectal Cancer Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Bio Mérieux Recent Developments and Future Plans
  • 2.7 Bio-Rad Life Medicine
    • 2.7.1 Bio-Rad Life Medicine Details
    • 2.7.2 Bio-Rad Life Medicine Major Business
    • 2.7.3 Bio-Rad Life Medicine Colorectal Cancer Molecular Diagnostics Kit Product and Solutions
    • 2.7.4 Bio-Rad Life Medicine Colorectal Cancer Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Bio-Rad Life Medicine Recent Developments and Future Plans
  • 2.8 Agilent
    • 2.8.1 Agilent Details
    • 2.8.2 Agilent Major Business
    • 2.8.3 Agilent Colorectal Cancer Molecular Diagnostics Kit Product and Solutions
    • 2.8.4 Agilent Colorectal Cancer Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Agilent Recent Developments and Future Plans
  • 2.9 Daan Gene
    • 2.9.1 Daan Gene Details
    • 2.9.2 Daan Gene Major Business
    • 2.9.3 Daan Gene Colorectal Cancer Molecular Diagnostics Kit Product and Solutions
    • 2.9.4 Daan Gene Colorectal Cancer Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Daan Gene Recent Developments and Future Plans
  • 2.10 Ed Bio
    • 2.10.1 Ed Bio Details
    • 2.10.2 Ed Bio Major Business
    • 2.10.3 Ed Bio Colorectal Cancer Molecular Diagnostics Kit Product and Solutions
    • 2.10.4 Ed Bio Colorectal Cancer Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Ed Bio Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Colorectal Cancer Molecular Diagnostics Kit Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Colorectal Cancer Molecular Diagnostics Kit by Company Revenue
    • 3.2.2 Top 3 Colorectal Cancer Molecular Diagnostics Kit Players Market Share in 2025
    • 3.2.3 Top 6 Colorectal Cancer Molecular Diagnostics Kit Players Market Share in 2025
  • 3.3 Colorectal Cancer Molecular Diagnostics Kit Market: Overall Company Footprint Analysis
    • 3.3.1 Colorectal Cancer Molecular Diagnostics Kit Market: Region Footprint
    • 3.3.2 Colorectal Cancer Molecular Diagnostics Kit Market: Company Product Type Footprint
    • 3.3.3 Colorectal Cancer Molecular Diagnostics Kit Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Colorectal Cancer Molecular Diagnostics Kit Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Colorectal Cancer Molecular Diagnostics Kit Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Colorectal Cancer Molecular Diagnostics Kit Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Colorectal Cancer Molecular Diagnostics Kit Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Colorectal Cancer Molecular Diagnostics Kit Consumption Value by Type (2021-2032)
  • 6.2 North America Colorectal Cancer Molecular Diagnostics Kit Market Size by Application (2021-2032)
  • 6.3 North America Colorectal Cancer Molecular Diagnostics Kit Market Size by Country
    • 6.3.1 North America Colorectal Cancer Molecular Diagnostics Kit Consumption Value by Country (2021-2032)
    • 6.3.2 United States Colorectal Cancer Molecular Diagnostics Kit Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Colorectal Cancer Molecular Diagnostics Kit Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Colorectal Cancer Molecular Diagnostics Kit Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Colorectal Cancer Molecular Diagnostics Kit Consumption Value by Type (2021-2032)
  • 7.2 Europe Colorectal Cancer Molecular Diagnostics Kit Consumption Value by Application (2021-2032)
  • 7.3 Europe Colorectal Cancer Molecular Diagnostics Kit Market Size by Country
    • 7.3.1 Europe Colorectal Cancer Molecular Diagnostics Kit Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Colorectal Cancer Molecular Diagnostics Kit Market Size and Forecast (2021-2032)
    • 7.3.3 France Colorectal Cancer Molecular Diagnostics Kit Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Colorectal Cancer Molecular Diagnostics Kit Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Colorectal Cancer Molecular Diagnostics Kit Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Colorectal Cancer Molecular Diagnostics Kit Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Kit Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Kit Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Kit Market Size by Region
    • 8.3.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Kit Consumption Value by Region (2021-2032)
    • 8.3.2 China Colorectal Cancer Molecular Diagnostics Kit Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Colorectal Cancer Molecular Diagnostics Kit Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Colorectal Cancer Molecular Diagnostics Kit Market Size and Forecast (2021-2032)
    • 8.3.5 India Colorectal Cancer Molecular Diagnostics Kit Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Colorectal Cancer Molecular Diagnostics Kit Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Colorectal Cancer Molecular Diagnostics Kit Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Colorectal Cancer Molecular Diagnostics Kit Consumption Value by Type (2021-2032)
  • 9.2 South America Colorectal Cancer Molecular Diagnostics Kit Consumption Value by Application (2021-2032)
  • 9.3 South America Colorectal Cancer Molecular Diagnostics Kit Market Size by Country
    • 9.3.1 South America Colorectal Cancer Molecular Diagnostics Kit Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Colorectal Cancer Molecular Diagnostics Kit Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Colorectal Cancer Molecular Diagnostics Kit Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Kit Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Kit Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Kit Market Size by Country
    • 10.3.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Kit Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Colorectal Cancer Molecular Diagnostics Kit Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Colorectal Cancer Molecular Diagnostics Kit Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Colorectal Cancer Molecular Diagnostics Kit Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Colorectal Cancer Molecular Diagnostics Kit Market Drivers
  • 11.2 Colorectal Cancer Molecular Diagnostics Kit Market Restraints
  • 11.3 Colorectal Cancer Molecular Diagnostics Kit Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Colorectal Cancer Molecular Diagnostics Kit Industry Chain
  • 12.2 Colorectal Cancer Molecular Diagnostics Kit Upstream Analysis
  • 12.3 Colorectal Cancer Molecular Diagnostics Kit Midstream Analysis
  • 12.4 Colorectal Cancer Molecular Diagnostics Kit Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Colorectal Cancer Molecular Diagnostics Kit market size was valued at US$ 1018 million in 2025 and is forecast to a readjusted size of US$ 2503 million by 2032 with a CAGR of 13.9% during review period.
    The main techniques involved in molecular testing for CRC are PCR based methods, DNA sequencing and immunohistochemistry analysis of tissue sections. These methods are currently used for diagnosis of Lynch syndrome by detection of MSI phenotype and discriminating them from sporadic CRC by looking for BRAF mutation.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Colorectal Cancer Molecular Diagnostics Kit market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Colorectal Cancer Molecular Diagnostics Kit market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Colorectal Cancer Molecular Diagnostics Kit market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Colorectal Cancer Molecular Diagnostics Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Colorectal Cancer Molecular Diagnostics Kit market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Colorectal Cancer Molecular Diagnostics Kit
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Colorectal Cancer Molecular Diagnostics Kit market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, Thermo Fisher, Kej, Illumina, Bio Mérieux, Bio-Rad Life Medicine, Agilent, Daan Gene, Ed Bio, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Colorectal Cancer Molecular Diagnostics Kit market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    PCR
    Molecular Hybridization
    Biochip
    Other
    Market segment by Application
    Hospital
    Third-party Testing Agency
    Other
    Market segment by players, this report covers
    Roche
    Abbott
    Thermo Fisher
    Kej
    Illumina
    Bio Mérieux
    Bio-Rad Life Medicine
    Agilent
    Daan Gene
    Ed Bio
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Colorectal Cancer Molecular Diagnostics Kit product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Colorectal Cancer Molecular Diagnostics Kit, with revenue, gross margin, and global market share of Colorectal Cancer Molecular Diagnostics Kit from 2021 to 2026.
    Chapter 3, the Colorectal Cancer Molecular Diagnostics Kit competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Colorectal Cancer Molecular Diagnostics Kit market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Colorectal Cancer Molecular Diagnostics Kit.
    Chapter 13, to describe Colorectal Cancer Molecular Diagnostics Kit research findings and conclusion.

    Buy now